|
DUSP11 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.601700E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.612400E-02 |
| Normal-vs-Stage2 |
2.08849999999705E-05 |
| Normal-vs-Stage3 |
3.707500E-02 |
| Normal-vs-Stage4 |
3.537600E-03 |
| Stage1-vs-Stage2 |
1.775590E-04 |
| Stage1-vs-Stage3 |
5.352000E-01 |
| Stage1-vs-Stage4 |
1.368580E-01 |
| Stage2-vs-Stage3 |
4.337100E-03 |
| Stage2-vs-Stage4 |
4.991600E-02 |
| Stage3-vs-Stage4 |
3.276600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.138100E-02 |
| Normal-vs-AfricanAmerican |
8.505700E-02 |
| Normal-vs-Asian |
1.502970E-01 |
| Caucasian-vs-AfricanAmerican |
7.175200E-01 |
| Caucasian-vs-Asian |
8.918400E-01 |
| AfricanAmerican-vs-Asian |
7.094600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.541400E-03 |
| Normal-vs-Female |
8.699400E-03 |
| Male-vs-Female |
5.684800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.093800E-01 |
| Normal-vs-Age(41-60Yrs) |
4.944700E-03 |
| Normal-vs-Age(61-80Yrs) |
1.155180E-04 |
| Normal-vs-Age(81-100Yrs) |
5.247800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.515600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.378220E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.918400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.874200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.600000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.269200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.217600E-01 |
| Classical-VS-Follicular |
3.7806000552365E-09 |
| Classical-VS-Other |
7.928200E-01 |
| Classical-VS-Normal |
3.105200E-01 |
| Tall-VS-Follicular |
4.29130000000333E-05 |
| Tall-VS-Other |
5.515800E-01 |
| Tall-VS-Normal |
8.725400E-01 |
| Follicular-VS-Other |
9.189800E-02 |
| Follicular-VS-Normal |
4.14509999657753E-08 |
| Other-VS-Normal |
5.127800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.8943000000069E-05 |
| Normal-vs-N1 |
3.151600E-02 |
| N0-vs-N1 |
2.870400E-01 |
|
|
